Testing effectiveness (Phase 2)Looking for participantsNCT06963905What this trial is testingSaci Nivo Rela for TNBCWho this might be right forMetastatic Triple-negative Breast Cancer Yale University 60
Not applicableTemporarily pausedNCT04638751What this trial is testingARGONAUT: Stool and Blood Sample Bank for Cancer PatientsWho this might be right forNon-small Cell Lung CancerColorectal CancerTriple Negative Breast Cancer+1 more Persephone Biosciences 5,000
Early research (Phase 1)Active Not RecruitingNCT04360941What this trial is testingPAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerWho this might be right forTriple Negative Breast CancerLocally Advanced Breast CancerRecurrent Breast Cancer+3 more Royal Marsden NHS Foundation Trust 45
Early research (Phase 1)Looking for participantsNCT05422794What this trial is testingTesting the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Triple-Negative Breast Carcinoma+2 more National Cancer Institute (NCI)
Not applicableWithdrawnNCT07226102What this trial is testingVirtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Endometrial Carcinoma+10 more City of Hope Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT04137653What this trial is testingTreatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCTWho this might be right forBreast Cancer Shengjing Hospital 1,498
Testing effectiveness (Phase 2)UnknownNCT04452370What this trial is testingOral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast CancerWho this might be right forTriple Negative Breast Cancer Chinese Academy of Medical Sciences 100
Early research (Phase 1)Study completedNCT01145430What this trial is testingVeliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast CancerWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeMale Breast Carcinoma+7 more National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)Ended earlyNCT03050398What this trial is testingA Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/RibociclibWho this might be right forBreast Cancer Novartis Pharmaceuticals 8
Very early researchLooking for participantsNCT06220214What this trial is testingNeoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast CancerWho this might be right forBreast CancerLocally Advanced Breast CancerNeoadjuvant Chemotherapy+3 more Alison Stopeck 30
Early research (Phase 1)Ended earlyNCT02706392What this trial is testingGenetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesWho this might be right forHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more Fred Hutchinson Cancer Center 21
Early research (Phase 1)Active Not RecruitingNCT06577987What this trial is testingSafety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor MalignanciesWho this might be right forAdvanced Solid TumorMetastatic Solid TumorRefractory Solid Tumor+7 more Circle Pharma 220
Early research (Phase 1)Study completedNCT05694364What this trial is testingDose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor MalignanciesWho this might be right forChronic Lymphocytic LeukemiaMantle Cell LymphomaAcute Lymphoblastic Leukemia+2 more H. Lee Moffitt Cancer Center and Research Institute 3
Testing effectiveness (Phase 2)Looking for participantsNCT06976944What this trial is testingPembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast CancerWho this might be right forRecurrent Triple-Negative Breast Cancer Yukinori Ozaki 24
Testing effectiveness (Phase 2)Ended earlyNCT03829501What this trial is testingA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesWho this might be right forSquamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Kymab Limited 222
Not applicableLooking for participantsNCT06476119What this trial is testingOPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating LymphocytesWho this might be right forBreast Cancer Stage ITriple Negative Breast Cancer (TNBC) The Netherlands Cancer Institute 490
Early research (Phase 1)Ended earlyNCT05035407What this trial is testingT Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial CancersWho this might be right forKita-kyushu Lung Cancer Antigen 1, Human National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT02898207What this trial is testingOlaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerWho this might be right forMetastatic High Grade Fallopian Tube Serous AdenocarcinomaMetastatic Malignant Solid NeoplasmMetastatic Primary Peritoneal Serous Adenocarcinoma+16 more National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)WithdrawnNCT04149444What this trial is testingTrifluridine/Tipiracil in Triple Negative Metastatic Breast CancerWho this might be right forMetastatic Triple Negative Breast Cancer AHS Cancer Control Alberta
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07786428What this trial is testingTailored Neoadjuvant Chemoimmunotherapy for Stage I TNBCWho this might be right forTriple-Negative Breast Cancer (TNBC) University of Texas Southwestern Medical Center 60